Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 27;94(4):469-72.
doi: 10.1038/sj.bjc.6602974.

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening

D M Greenfield  1 , J Wright, J E Brown, B W Hancock, H A Davies, L O'Toole, C Eiser, R E Coleman, R J Ross
Affiliations

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening

D M Greenfield et al. Br J Cancer. .

Abstract

Assessment of late effects in a cohort of female Hodgkin's lymphoma patients treated with mantle radiotherapy, identified from the DoH breast cancer screening recall showed high mortality and frequent undiagnosed abnormalities in tissues affected by radiotherapy. With increasing age, this patient group may suffer premature cardiac and respiratory morbidity.

PubMed Disclaimer

References

    1. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22: 3139–3148 - PubMed
    1. Allavena C, Conroy T, Alletti P, Bey P, Lederlin P (1992) Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer 65: 908–912 - PMC - PubMed
    1. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996: 745–751 - PubMed
    1. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21: 4386–4394 - PubMed
    1. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C (1998) The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher after combined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Haematologica 83: 812–823 - PubMed

Publication types